It's not April yet, ads start then according to the company unless there's been a change in the plan.
looks like more old news BS. Who cares about more "encouraging" pre clinical findings. Where are the HUMAN data. They are the slowest, most over-promising, under delivering company...Please IDEX taks our CEO!!!
add to that 1450 April 33 calls. That's a very bullish prediction by the call buyer, assuming they were initiated as buys. Did anyone see the print and if they were on the bid, or offer? Also could be part of a strategy, sell one buy another, or part or a stock strategy, buy and write, or short and buy puts. Anyway, thanks for pointing this out.
most market makers just facilitate trading, they get an order, execute it and trade out almost immediately. There are a few MM's that trade for their own account, mostly just technical traders. MM's are not in business to manipulate stocks, they are all about reacting to, or adding to the flow of orders.
trade it then and stop whining. It's always the people who have no idea how the markets work that complain about MM's. The stock went from $2 to 30, they offered new shares, insiders sold a bunch of shares, there's likely no new catalyst until late year, what are you expecting? Trade it, or just buy and hold on for the ride. Biotech is volatile, this could go to $40+ or back to $2 if there's a major, unexpected problem.
what is the shorts fascination with all things related to feces? Is this just a lack of vocabulary, or is it in the short playbook? Just curious piggy-dog. Good to see you positing, always fun. I think you are losing some of your contra-indicator value.
Nobody will communicate with Tele the loser, so he keeps replying to his/its own posts, very sad. Now you are an expert in Pharma TV ads? Brilliant!
Interesting, I wonder what type of physicians were surveyed, how many, etc. I agree with the conclusion. It would be great for Kad if the Kad + placebo arm performed almost as well as Kad + Perj. When do they expect top line data?
Street note, insider bought and position reduced 713% what a flippin moron. Please do as I have done and email the author!
8K- Looks like the CFO is cashing in and cashing out of his options and management is adding a new cash incentive. Typical biotech, they always maximize their personal returns. Shareholders take the risk, management gets a nice salary and options, no need to be pigs. IMO.
yes, it's worse than dog breath for the buyers and holders. It's not so bad for the range traders, or option sellers.
looks like the writing is on the wall there, warning, warning, danger Will Robinson!
there's nothing left to report other than whether, or not the dealers took the over allotment. I think their net price after commission is under $27, so they will probably take the extra shares if the price holds up, but maybe not. They earned a big fee something like $10MM.
large potential market, high risk, they will need to raise cash. LJPC has been a serial loser, money burner, shareholder value destroyer and reverse splitter. I think BB's are an owner now, so you might get a good ride if timed right, but I can't endorse them based on history and lack of DD.
so idiots, or deceivers like you can write deceptive trash posts on the Yahoo MB and earn .05 a post. Get a real job loser!